135 related articles for article (PubMed ID: 10516236)
1. Cardiovascular and renal responses produced by central orphanin FQ/nociceptin occur independent of renal nerves.
Kapusta DR; Kenigs VA
Am J Physiol; 1999 Oct; 277(4):R987-95. PubMed ID: 10516236
[TBL] [Abstract][Full Text] [Related]
2. Functional selectivity of nociceptin/orphanin FQ peptide receptor partial agonists on cardiovascular and renal function.
Kapusta DR; Burmeister MA; Calo' G; Guerrini R; Gottlieb HB; Kenigs VA
J Pharmacol Exp Ther; 2005 Aug; 314(2):643-51. PubMed ID: 15855356
[TBL] [Abstract][Full Text] [Related]
3. Nociceptin/orphanin FQ modulates the cardiovascular, but not renal, responses to stress in spontaneously hypertensive rats.
Kapusta DR; Dayan LA; Kenigs VA
Clin Exp Pharmacol Physiol; 2002 Mar; 29(3):254-9. PubMed ID: 11906494
[TBL] [Abstract][Full Text] [Related]
4. Tonic nociceptinergic inputs to neurons in the hypothalamic paraventricular nucleus contribute to sympathetic vasomotor tone and water and electrolyte homeostasis in conscious rats.
Krowicki ZK; Kapusta DR
J Pharmacol Exp Ther; 2006 Apr; 317(1):446-53. PubMed ID: 16407463
[TBL] [Abstract][Full Text] [Related]
5. Central administration of [Phe1psi(CH2-NH)Gly2]nociceptin(1-13)-NH2 and orphanin FQ/nociceptin (OFQ/N) produce similar cardiovascular and renal responses in conscious rats.
Kapusta DR; Chang JK; Kenigs VA
J Pharmacol Exp Ther; 1999 Apr; 289(1):173-80. PubMed ID: 10087001
[TBL] [Abstract][Full Text] [Related]
6. Central G-alpha subunit protein-mediated control of cardiovascular function, urine output, and vasopressin secretion in conscious Sprague-Dawley rats.
Wainford RD; Kurtz K; Kapusta DR
Am J Physiol Regul Integr Comp Physiol; 2008 Aug; 295(2):R535-42. PubMed ID: 18525017
[TBL] [Abstract][Full Text] [Related]
7. Chronic high-NaCl intake prolongs the cardiorenal responses to central N/OFQ and produces regional changes in the endogenous brain NOP receptor system.
Wainford RD; Kapusta DR
Am J Physiol Regul Integr Comp Physiol; 2009 Feb; 296(2):R280-8. PubMed ID: 18987291
[TBL] [Abstract][Full Text] [Related]
8. Centrally administered nociceptin/orphanin FQ (N/OFQ) evokes bradycardia, hypotension, and diuresis in mice via activation of central N/OFQ peptide receptors.
Burmeister MA; Kapusta DR
J Pharmacol Exp Ther; 2007 Jul; 322(1):324-31. PubMed ID: 17452419
[TBL] [Abstract][Full Text] [Related]
9. Nociceptin/orphanin FQ (N/OFQ)-evoked bradycardia, hypotension, and diuresis are absent in N/OFQ peptide (NOP) receptor knockout mice.
Burmeister MA; Ansonoff MA; Pintar JE; Kapusta DR
J Pharmacol Exp Ther; 2008 Sep; 326(3):897-904. PubMed ID: 18539652
[TBL] [Abstract][Full Text] [Related]
10. Cardiovascular and renal effects of nociceptin/orphanin FQ: a new mediator to target?
Doggrell SA
Curr Opin Investig Drugs; 2007 Sep; 8(9):742-9. PubMed ID: 17729186
[TBL] [Abstract][Full Text] [Related]
11. Neurohumoral effects of orphanin FQ/nociceptin: relevance to cardiovascular and renal function.
Kapusta DR
Peptides; 2000 Jul; 21(7):1081-99. PubMed ID: 10998543
[TBL] [Abstract][Full Text] [Related]
12. Diuretic and antinatriuretic responses produced by the endogenous opioid-like peptide, nociceptin (orphanin FQ).
Kapusta DR; Sezen SF; Chang JK; Lippton H; Kenigs VA
Life Sci; 1997; 60(1):PL15-21. PubMed ID: 8995537
[TBL] [Abstract][Full Text] [Related]
13. Nociceptin/orphanin FQ increases blood pressure and heart rate via sympathetic activation in sheep.
Arndt ML; Wu D; Soong Y; Szeto HH
Peptides; 1999; 20(4):465-70. PubMed ID: 10458516
[TBL] [Abstract][Full Text] [Related]
14. Nociceptin modulates renal sympathetic nerve activity through a central action in conscious rats.
Shirasaka T; Kunitake T; Kato K; Takasaki M; Kannan H
Am J Physiol; 1999 Oct; 277(4):R1025-32. PubMed ID: 10516241
[TBL] [Abstract][Full Text] [Related]
15. [Effect of OFQ injection into intracerebroventricular and preoptic area on blood pressure and heart rate in rats].
Zhang X; Zhu CB; Shu H; Liu J; Wang YY; Wang Y; Liu HY
Sheng Li Xue Bao; 1999 Oct; 51(5):580-4. PubMed ID: 11498957
[TBL] [Abstract][Full Text] [Related]
16. Central actions of adrenomedullin on cardiovascular parameters and sympathetic outflow in conscious rats.
Saita M; Shimokawa A; Kunitake T; Kato K; Hanamori T; Kitamura K; Eto T; Kannan H
Am J Physiol; 1998 Apr; 274(4):R979-84. PubMed ID: 9575959
[TBL] [Abstract][Full Text] [Related]
17. Differential cardiovascular and renal responses produced by microinjection of the {kappa}-opioid U-50488H [(trans-3,4-dichloro-N-methyl-N-[2-(1-pyrrolidinyl)cyclohexyl]-benzene-acetamide) methane sulfonate] into subregions of the paraventricular nucleus.
Gottlieb HB; Varner KJ; Kenigs VA; Cabral AM; Kapusta DR
J Pharmacol Exp Ther; 2005 Feb; 312(2):678-85. PubMed ID: 15381735
[TBL] [Abstract][Full Text] [Related]
18. Central mu opioid receptor-mediated changes in renal function in conscious rats.
Kapusta DR; Obih JC; Dibona GF
J Pharmacol Exp Ther; 1993 Apr; 265(1):134-43. PubMed ID: 8097241
[TBL] [Abstract][Full Text] [Related]
19. Endogenous central kappa-opioid systems augment renal sympathetic nerve activity to maximally retain urinary sodium during hypotonic saline volume expansion.
Gottlieb HB; Kapusta DR
Am J Physiol Regul Integr Comp Physiol; 2005 Nov; 289(5):R1289-96. PubMed ID: 15976307
[TBL] [Abstract][Full Text] [Related]
20. Effects of centrally administered endothelin-3 on renal sympathetic nerve activity and renal blood flow in conscious rats.
Kannan H; Tanaka H; Ueta Y; Hayashida Y; Kunitake T; Yamashita H
J Auton Nerv Syst; 1994 Oct; 49(2):105-13. PubMed ID: 7806763
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
